40 / 88
40
Scientific Programme /
Tuesday, 20 June 2017
WFSBP 2017
TUE
T45: SLEEP DISORDERS: BASIC/ CLINICAL
TFS-04
WFSBP TASK FORCE SYMPOSIUM
11:15–12:45
Congress Hall A 3
Sleep in depression and cognition – from research to
clinical practice
Chair:
Edith Holsboer-Trachsler, Switzerland
Co-Chair: Birendra N. Mallick, India
001
Sleep as biomarker: Predictor of emotional
regulation and depression
Martin Hatzinger, Switzerland
002
Sleep in dementia: A biomarker of cognition?
Dimitris Dikeos, Greece
003
Sleep and synaptic dysfunction in depression
Anne Eckert, Switzerland
004
REM sleep and prevention of neurodegeneration:
Role of noradrenaline
Birendra N. Mallick, India
T9: COGNITIVE NEUROSCIENCE
S-36
SYMPOSIUM
11:15–12:45
Auditorium 12
The role of the nucleus accumbens in psychiatry
Chair:
Jens Kuhn, Germany
Co-Chair: Leonhard Schilbach, Germany
001
The anatomy of the nucleus accumbens
Ioannis Mavridis, Greece
002
The role of nucleus accumbens in social cognition
Leonhard Schilbach, Germany
004
Deep brain stimulation of the nucleus accumbens
Sina Kohl, Germany
T11: DEPRESSION: BASIC/ CLINICAL
S-37
SYMPOSIUM
11:15–12:45
Auditorium 10
Neurobiologic imaging studies of mood disorders,
neurogenetics and antidepressant action with
positron emission tomography
Chair:
J. John Mann, USA
Co-Chair: Gitte Moos Knudsen, Denmark
001
Familial transmission of 5-HT1A autoreceptor
up-regulation: An impaired serotonnergic endopheno-
type in mood disorders
J. John Mann, USA
002
Molecular neuroimaging and genetics
Gitte Moos Knudsen, Denmark
003
Predictiveness of clinical and peripheral markers
for PET measurement of monoamine oxidase A:
Implications for biomarker development in major
depressive disorder and prevention of postpartum
depression
Jeffrey Meyer, Canada
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-38
SYMPOSIUM
11:15–12:45
Auditorium 11
Treatment resistant schizophrenia: Definitions,
psychobiology and clinical treatment
Chair:
John Kane, USA
Co-Chair: Ofer Agid, Canada
001
Methodological issues in clinical trial designs
for TRS
John Kane, USA
002
A longitudinal perspective on the evolution
of treatment resistance
Ofer Agid, Canada
003
The biology of treatment resistance
Oliver Howes, United Kingdom
004
Definitions and epidemiology of treatment
resistance
Christoph U. Correll, USA
T49: SUICIDE: BASIC/ CLINICAL
WS-06
WORKSHOP
11:15–12:45
B3 M1-M2
Neurobiology of suicidal behaviour
Chair:
Leo Sher, USA
Co-Chair: Zoltan Rihmer, Hungary
001
Testosterone and suicidal behavior in men and
women
Leo Sher, USA
002
Suicide in men: Clinical and biological correlates
Zoltan Rihmer, Hungary
003
Neuroinflammatory biomarkers of suicidal
behavior
Jussi Jokinen, Sweden
004
Endophenotypes of suicidal behavior for genetic
research
Xénia Gonda, Hungary